Sage Therapeutics, Inc.
83.83 -0.44(-0.52%) Date: Jul 26, 4:48PM EDT
Musk said thank you to customers for believing in Tesla
Plans to seek certification of its Corporate Governance program and study the potential for a Level 2 listing on the Sao Paulo stock exchange (B3) were announced
Square Founder and CEO, Jack Dorsey, and CFO, Sarah Friar, presented this afternoon at JPMorgan's TMT Conference, echoing many of the comments made at their analyst day last week
Given the market reaction to the day and more sell-side analysts at Neutral and Sell (60%) than Buy, sentiment on this stock is already lukewarm
The firm views potential opportunities in PPD, MDD, ET and PD as the main value drivers for SAGE long term given all are areas of high unmet need and large addressable markets